← Back to graph

Prescription

adalimumab-ryvk Simlandi

Selected indexed studies

Evaluation of Injection Site Pain and Adherence in Patients Transitioning from a High to Low Volume Adalimumab Formulation (AVT02, Simlandi®) Across Multiple Indications (EASE PAIN). (Rheumatol Ther, 2026) [PMID:41963765]

_Worker-drafted node — pending editorial review._

Connections

No connections recorded yet.

Sources

Evaluation of Injection Site Pain and Adherence in Patients Transitioning from a High to Low Volume Adalimumab Formulation (AVT02, Simlandi®) Across Multiple Indications (EASE PAIN). (2026) pubmed

Local graph